A 77-year-old woman with a history of coronary artery disease was admitted to our hospital to undergo an examination for the onset of recurrent hematochezia requiring intermittent transfusions. Four months prior to admission, clopidogrel was administered in addition to aspirin after percutaneous coronary intervention. Esophagogastroduodenoscopy and colonoscopy were not able to identify any responsible lesions. Retrograde single-balloon enteroscopy revealed a submucosal tumor with a shallow ulcer in the distal ileum (Picture 1). Abdominal ultrasound showed a hyperechoic mass in right lower quadrant (Picture 2). Computed to-
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